AG 1406

CAS No. 71308-34-4

AG 1406( —— )

Catalog No. M17575 CAS No. 71308-34-4

AG 1406 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 75 In Stock
2MG 36 In Stock
5MG 57 In Stock
10MG 85 In Stock
25MG 170 In Stock
50MG 259 In Stock
100MG 384 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AG 1406
  • Note
    Research use only, not for human use.
  • Brief Description
    AG 1406 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2.
  • Description
    AG 1406 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    71308-34-4
  • Formula Weight
    254.32
  • Molecular Formula
    C16H18N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)c1cc(cc(c1O)C(C)C)C=C(C#N)C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BC 11 hydrobromide

    BC 11 hydrobromide is a selective TMPRSS2 and urokinase (uPA) inhibitor.BC-11 induces diminished mitochondrial activity, promotes reactive oxygen species production, and promotes apoptosis, and can be used in the study of breast cancer.

  • Sodium taurochenodeo...

    Sodium taurochenodeoxycholate is one of the main bioactive substances of animals' bile acid.?Sodium taurochenodeoxycholate induces apoptosis and shows obvious anti-inflammatory and immune regulation properties. It can increase glucose-induced insulin secretion and stimulate the electrical activity of α2-cells and enhance cytosolic Ca(2+) concentration ([Ca(2+)](c)).

  • M3541

    M3541 is a selectively potent and orally active ATM inhibitor with potential antitumor activity.M-3541 inhibits ATM kinase activity and ATM-mediated signaling by binding to ATM.